Skip to main
ADNT
ADNT logo

Adient (ADNT) Stock Forecast & Price Target

Adient (ADNT) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 13%
Buy 13%
Hold 63%
Sell 13%
Strong Sell 0%

Bulls say

Adient, a leading seating supplier in the automotive industry, reported consolidated revenue of $14.5 billion for fiscal 2025, excluding joint venture sales, indicating a robust financial position. The company anticipates significant growth through increased market share from onshored production, with potential targeted share gains from reshored programs expected to more than double current figures. Additionally, management projects margin expansion to between 5.0% and 5.5% over the next 2-3 years, further supporting a positive outlook for the company's financial health.

Bears say

Adient's negative outlook is primarily driven by persistent challenges stemming from loss-making metals contracts and uncompetitive plants, which have significantly hindered profitability and cash flow since its spin-off from Johnson Controls. The company has also faced a decline in vehicle production in the EMEA region, coupled with an unfavorable production mix that adversely affects revenue. Additionally, ongoing geopolitical and macroeconomic factors are expected to further exacerbate these challenges, particularly for European production.

Adient (ADNT) has been analyzed by 8 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 13% recommend Buy, 63% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adient and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adient (ADNT) Forecast

Analysts have given Adient (ADNT) a Hold based on their latest research and market trends.

According to 8 analysts, Adient (ADNT) has a Hold consensus rating as of Dec 10, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adient (ADNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.